Altered circadian relationship between serum nitric oxide, carbon dioxide, and uric acid in multiple sclerosis

Chronobiology International

Volumn 21, Issue 4-5, 2004, Pages 739-758

  Kanabrocki, E L ^a   Ryan, M D ^a   Hermida, R C ^b   Ayala, D E ^b   Scott, G S ^c,d   Murray, D ^e   Bremner, W F ^f   Third, J L H C ^a   Johnson, M C ^a   Foley, S ^a   Van Cauteren, J ^a   Shah, F ^a   Shirazi, P ^a   Nemchausky, B A ^a   Hooper, D C ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIGO   (Spain)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e Oxis Research   (United States)

^f MacNeal Cardiology Group   (United States)

Author keywords

Carbon dioxide; Circadian rhythm; Multiple sclerosis; Nitric oxide; Uric acid

Indexed keywords

BETA1A INTERFERON; CARBON DIOXIDE; GLATIRAMER; NITRATE; NITRIC OXIDE; NITRITE; URIC ACID;

ADULT; ARTICLE; CARBON DIOXIDE BLOOD LEVEL; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MALE; METABOLITE; MULTIPLE SCLEROSIS; OXYGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; AGED; CARBON DIOXIDE; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NITRIC OXIDE; PEROXYNITROUS ACID; REFERENCE VALUES; URIC ACID;

EID: 4544341906     PISSN: 07420528     EISSN: None     Source Type: Journal    
DOI: 10.1081/CBI-200025981     Document Type: Article

References (50)

1. Beckman, J. S. (1991). The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Developmental Physiol. 15:53-59.
2. Bingham, C., Arbogast, B., Cornellisen, G., Lee, J. V., Halberg, F. (1982). Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia 9:397-439.
3. Copeman, W. S. C. (1883). A short history of gout. The Genuine Works of Hippocrates Translated by Francis Adams, 1964. Vol. I and II. New York: Berkeley University, California Press.
4. - in inflammatory CNS demyelination. J. Neuroimmunol. 80:121-130.
5. Cross, A. H., Manning, P. T., Keeling, R. M., Schmidt, R. E., Misko, T. P. (1998). Peroxynitrite formation within the central nervous system in active multiple sclerosis. J. Neuroimmunol. 88:45-56.
6. Davis, J. W., Grandinetti, A., Waslien, C. I., Ross, G. W., White, L. R., Morens, D. M. (1996). Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am. J. Epidemiol. 144(5):480-484.
7. Drulovic, J., Dujmovic, I., Stojsavljevic, N., Mesaros, S., Andjelkovic, S., Miljkovic, D., Peric, V., Dragutovic, G., Marinkovic, J., Levic, Z., Mostarica Stojkovic, M. (2001). Uric acid levels in sera from patients with multiple sclerosis. J. Neurol. 248:121-126.
8. Fernandez, J. R., Hermida, R. C. (1998). Inferential statistical method for analysis of nonsinosoidal hybrid series with unequidistant observations. Chronobiol. Int. 15:191-204.
9. Fernandez, J. R., Mojon, A., Hermida, R. C. (2004). Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 21(3):469-484.
10. Freal, J. E., Kraft, G. H., Coryell, J. K. (1984). Symptomatic fatigue in multiple sclerosis. Arch. Phys. Med. Rehabil. 65:135-138.
11. Gucuyener, K., Ergenekon, E., Erbas, D., Pinarli, G., Serdaroglu. (2000). The serum nitric oxide levels in patients with Duchenne muscular dystrophy. Brain Development 22(3):181-183.
12. Hermida, R. C. (1987). Chronobiologic data analysis systems with emphasis in chronotherapeutic marker rhythmometry and chronoepidemiologic risk assessment. In: Scheving, L. E., Halberg, F., Ehret, C. F., eds. Chronobiotechnology and Chronobiological Engineering. NATO ASI series no 120; Dordrecht: Martinus Nijhoff, pp. 88-119.
13. -: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA. 94:2528-2533.
14. Hooper, D. C., Spitsin, S. V., Kean, R. B., Champion, J. M., Dickson, G. M., Chaudhry, I., Koprowski, H. (1998). Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Nat. Acad. Sci. USA 95:675-680.
15. Hooper, D. C., Scott, G. S., Zborek, A., Mikheeva, T., Kean, R. B., Koprowski, H., Spitsin, S. V. (2000). Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J. 14:691-698.
16. Hooper, D. C., Kean, R. B., Scott, G. S., Spitsin, S. V., Morimoto, K., Bette, M., Rohrenbeck, A. M., Dietzschold, B., Weihe, E. (2001). The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J. Immunol. 167:3470-3477.
17. Kanabrocki, E. L., Sothern, R. B., Scheving, L. E., Vesely, D. L., Tsai, T. H., Shelstad, J., Cournoyer, C., Greco, J., Mermall, H., Nemchausky, B. M., Bushnell, D. L., Kaplan, E., Kahn, S., Augustine, G., Holmes, E., Rumbyrt, J., Sturtevant, R. P., Sturtevant, F., Bremmer, F., Third, J. L. H. C., McCormick, J. B., Mudd, C. A., Dawson, S., Olwin, J. H., Sackett-Lundeen, L., Haus, E., Halberg, F., Pauly, J. E., Hrushesky, W. J. M. (1990a). Circadian reference data for men in fifth decade of life. Prog. Clin. Biol. Res. 341A:771-781.
18. Kanabrocki, E. L., Sothern, R. B., Scheving, L. E., Vesely, D. L., Tsai, T. H., Shelstad, J., Cournoyer, C., Greco, J., Mermall, H., Ferlin, H., Nemchausky, B. M., Bushnell, D. L., Kaplan, E., Kahn, S., Augustine, G., Holmes, E., Rumbyrt, J., Sturtevant, R. P., Sturtevant, F., Bremmer, F., Third, J. L. H. C., McCormick, J. B., Dawson, S., Sackett-Lundeen, L., Haus, E., Halberg, F., Pauly, J. E., Olwin, J. H. (1990b). Reference values for circadian rhythms of 98 variables in clinically healthy men in the fifth decade of life. Chronobiol. Int. 7:445-461.
19. Kanabrocki, E. L., McCormick, J. B., Hermida, R. C., Bremner, W. F., Third, J. L. H. C., Ryan, M. D., Hoppenstaedt, D. A., Farced, J., Nemchausky, B. A., Shirazi, P., Scheving, L. E., Olwin, J. H. (2000). Circadian interrelationship between serum uric acid and nitric oxide in adult male subjects. JAMA 283(17):2240-2241.
20. Kastenbauer, S., Pfister, H. W. (2002). Protection against meningitis-associated central nervous system complications by uric acid. Med. Hypoth. 58:431.
21. Kastenbauer, S., Koedel, U., Pfister, H. W. (1999). Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J. Infect. Dis. 180:1164-1170.
22. Kean, R. B., Spitsin, S. V., Mikheeva, T., Scott, G. S., Hooper, D. C. (2000). The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the CNS in experimental allergic encephalomyelitis through maintenance of blood-CNS barrier integrity. J. Immunol. 165:6511-6518.
23. Koprowski, H., Spitsin, S. V., Hooper, D. C. (2001). Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Annals of Neurology 49:139.
24. Liu, J. S., Zhao, M. L., Brosnan, C. F., Lee, S. C. (2001). Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158:2057-2066.
25. Longo-Mbenza, B., Luila, E. L., Mbete, P., Vita, E. K. (1999). Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans? Int. J. Cordiol. 71:17-22.
26. Maesaka, J. K., Wolf-Klein, G., Piccione, J. M., Ma, C. M. (1993). Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer's disease. J. Am. Geriatr. Soc. 41:501-506.
27. McLaren, M., Kirk, G., Bolton-Smith, C., Belch, J. J. (2000). Seasonal variation in plasma levels of endothelin-1 and nitric oxide. Intern. Angiol. 19(4):351-353.
28. Mojon, A., Fernandez, J. R., Hermida, R. C. (1992). An interactive software package for chronobiologic time series analysis written for Macintosh computer. Chronbiol. Int. 9(6):403-412.
29. Moncada, S., Palmer, R. M. J., Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
30. Morris, M. E., Cantwell, C., Vowels, L., Dodd, K. (2002). Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 72(3):361-365.
31. Ochoa, J. B., Udekwu, A. O., Billiar, T. R., Curran, R. D., Cerra, F. B., Simmons, R. L., Peitzman, A. B. (1991). Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214:621-626.
32. Scott, G. S., Hooper, D. C. (2000). The role of uric acid in protecting the central nervous system from peroxynitrite-mediated pathology. Med. Hypoth. 56:95-100.
33. Scott, G. S., Spitsin, S. V., Kean, R. B., Mikheeva, T., Koprowski, H., Hooper, D. C. (2002). Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc. Natl. Acad. Sci. USA 99(25):16303-16308.
34. Sotgiu, S., Vanoli, M., Pugliatti, G., Fresu, V., Agnetti, I., Rostati, A. G. (1999). Correlation between urate level and clinical course of multiple sclerosis. J. Neuroimmunol. A53.
35. Sothern, R. B., Vesely, D. L., Kanabrocki, E. L., Bremner, F. W., Third, J. L. H. C., Boles, M. A., Nemchausky, B. M., Olwin, J. H., Scheving, L. E. (1995a). Blood pressure and atrial natriuretic peptides correlate throughout the day. Am. Heart J. 129:907-916.
36. Sothern, R. B., Vesely, D. L., Kanabrocki, E. L., Hermida, R. C., Bremner, F. W., Third, J. L. H. C., Boles, M. A., Nemchausky, B. M., Olwin, J. H., Scheving, L. E. (1995b). Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure. Chronobiol. Int. 12:106-120.
37. Spitsin, S. V., Scott, G. S., Kean, R. B., Mikheeva, T., Hooper, D. C. (2000). Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid. Neurosci. Lett. 292:137-141.
38. Spitsin, S., Hooper, D. C., Mikheeva, T., Koprowski, H. (2001a). Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins. Mult. Scler. 7:165-166.
39. Spitsin, S., Hooper, D. C., Leist, T., Streletz, L. J., Mikheeva, T., Koprowskil, H. (2001b). Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease. Mult. Scler. 7(5):313-319.
40. - in vivo from nitric oxide and Superoxide. Chemico-Biological Interactions 96:203-206.
41. Squadrito, S. L., Cueto, R., Splenser, A. E., Valavanidis, A., Zhang, H., Uppu, R. M., Pryor, W. A. (2000). Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch. Biochem. Biophys. 376:333-337.
42. Sumimo, H., Sato, K., Sakamaki, T., Kanda, T., Nakamura, T., Takahashi, T., Sakamoto, H., Kobayashi, T., Nagai, R. (1999). Reduced production of nitric oxide during haemodialysis. J. Hum. Hypertens. 13(7):437-422.
43. Taskiran, D., Sagduyu, A., Yuceyar, N., Kutay, F. Z., Pogun, S. (2000). Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic Lateral Sclerosis. Int. J. Neuroscience 101:65-72.
44. Teng, R. J., Ye, Y. Z., Parks, D. A., Beckman, J. S. (2002). Urate produced during hypoxia protects heart proteins from peroxynitrite-mediated protein nitration. Free Radical Biol. Med. 33:1243-1249.
45. Toncev, G., Milici, B., Toncev, S., Samardzic, G. (2002a). Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur. J. Neurol. 9:221-226.
46. Toncev, G., Milicic, B., Toncev, S., Samardzic, G. (2002b). High-dose methylprednisolone therapy in multiple sclerosis increases serum uric acid levels. Clin. Chem. Lab. Med. 40(5):505-508.
47. Touitou, Y., Portaluppi, F., Smolensky, M. H., Rensing, L. (2004). Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 21(1):161-170.
48. van der Veen, R. C., Hinton, D. R., Incardonna, F., Hofman, F. M. (1997). Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77:1-7.
49. Varela Eschavarria, A., Montes de Oca-Luna, R., Barrera-Saldana, H. A. (1988). Uricase protein sequences: conserved during hominid evolution but absent in humans. FASEB J. 2:3092-3096.
50. Yamamoto, T., Katayamam, I., Mishiokam, K. (1998). Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J. Rheumatology 25(2):314-317.